These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Biocompatibility of a polycarbonate membrane. A preliminary report. De Broe ME; van Waeleghem JP; Heyrman R; De Backer W Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165 [TBL] [Abstract][Full Text] [Related]
8. Acute renal failure: role of dialysis membrane biocompatibility. Pascual M; Swinford RD; Tolkoff-Rubin N Annu Rev Med; 1997; 48():467-76. PubMed ID: 9046977 [TBL] [Abstract][Full Text] [Related]
9. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure]. Hory B; Henriet MT Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023 [TBL] [Abstract][Full Text] [Related]
10. Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium? Nielsen AH; Knudsen F; Kristensen SD Nephron; 1985; 40(1):100-3. PubMed ID: 2987714 [TBL] [Abstract][Full Text] [Related]
11. Increased serum angiotensin-converting enzyme in end-stage renal disease. Rumpf KW; Brat A; Armstrong V; Scheler F Nephron; 1985; 40(2):248-9. PubMed ID: 2987717 [No Abstract] [Full Text] [Related]
12. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis. Jankova T; Tchankova P; Nenov D Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601 [TBL] [Abstract][Full Text] [Related]
13. [Unspecific increase of blood levels of angiotensin converting enzyme in chronic hemodialysis]. Leanza HJ; Vivas N; Garcia G; Rivarola G; Najun Zarazaga CJ Medicina (B Aires); 1994; 54(2):183. PubMed ID: 7997142 [No Abstract] [Full Text] [Related]
14. Artificial kidney: status of the art and new perspectives. Stefoni S; Cianciolo G; Colì L; Raimondi C; Dalmastri V; Donati G; Manna C; Grammatico F Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):111-2. PubMed ID: 12751828 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the biocompatibility of haemodialysis membranes. Schulman G; Hakim RM Nephrol Dial Transplant; 1991; 6 Suppl 2():10-3. PubMed ID: 1866056 [No Abstract] [Full Text] [Related]
16. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility? Ward RA Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427 [No Abstract] [Full Text] [Related]
18. Recent advances in the biocompatibility of haemodialysis membranes. Hakim RM Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426 [No Abstract] [Full Text] [Related]
19. Abdominal manifestations associated with use of a surface-treated AN69 membrane and ACEI during haemodialysis. Roux VD; Plaisance M Nephrol Dial Transplant; 2007 Jun; 22(6):1792-3. PubMed ID: 17314206 [No Abstract] [Full Text] [Related]
20. Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis. Kiss Z; Ambrus C; Kulcsár I; Szegedi J; Kiss I; ; J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1021-7. PubMed ID: 25002133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]